Evidence map›Paper›PMID 25885367›Full record

ReviewBMC psychiatry2015

Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence.

Julia B Baller, Emma E McGinty, Susan T Azrin, Denise Juliano-Bult, Gail L Daumit

Abstract readReview
In one paragraph

Review in BMC psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Search for Possible Associations ofPharmacogenomics and personalized medicine · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julia B BallerJohns Hopkins Bloomberg School of Public Health, 624 N Broadway St., Room 405, Baltimore, MD, 21205, USA. jballer@jhu.edu.
Emma E McGintyJohns Hopkins Bloomberg School of Public Health, 624 N Broadway St., Room 405, Baltimore, MD, 21205, USA. emcginty@jhu.edu.
Susan T AzrinNational Institute of Mental Health, 6001 Executive Boulevard, Room 7145 MSC 9631, Rockville, MD, 20852, USA. Susan.Azrin@nih.gov.
Denise Juliano-BultNational Institute of Mental Health, 6001 Executive Boulevard, Room 7145 MSC 9631, Rockville, MD, 20852, USA. Djuliano@mail.nih.gov.
Gail L DaumitJohns Hopkins School of Medicine, 2024 E Monument St, Suite 2-620, Baltimore, MD, 21205, USA. gdaumit@jhmi.edu.

Funding

Developing and Translating Interventions to Decrease Mortality Disparities in SMIK24MH093763 · NIMH · JOHNS HOPKINS UNIVERSITY · PI DAUMIT, GAIL L. · 2012 to 2016
$830k
NIMH NIH HHS K24 MH093763PHS HHS HHSN271201200576P
6 · The paper itself

Abstract

backgroundAdults with serious mental illness have a mortality rate two to three times higher than the overall US population, much of which is due to somatic conditions, especially cardiovascular disease. Given the disproportionately high prevalence of cardiovascular risk factors in the population with SMI, screening for these conditions is an important first step for timely diagnosis and appropriate treatment. This comprehensive literature review summarizes screening rates for cardiovascular risk factors in the population with serious mental illness.

methodsRelevant articles published between 2000 and 2013 were identified using the EMBASE, PsychInfo, PubMed, SCOPUS and Web of Science databases. We reviewed 10 studies measuring screening rates for obesity, diabetes, dyslipidemia, and hypertension in the population with serious mental illness. Two reviewers independently extracted information on screening rates, study population, and study setting.

resultsRates of screening varied considerably by time period, study population, and data source for all medical conditions. For example, rates of lipid testing for antipsychotic users ranged from 6% to 85%. For some conditions, rates of screening were consistently high. For example, screening rates for hypertension ranged from 79% - 88%.

conclusionsThere is considerable variation in screening of cardiovascular risk factors in the population with serious mental illness, with significant need for improvement in some study populations and settings. Implementation of standard screening protocols triggered by diagnosis of serious mental illness or antipsychotic use may be promising avenues for ensuring timely diagnosis and treatment of cardiovascular risk factors in this population.

Indexed as

AdultAntipsychotic AgentsCardiovascular DiseasesDiabetes MellitusDyslipidemiasEarly DiagnosisFemaleHumansHypertensionMaleMental DisordersObesityRisk FactorsYoung AdultAntipsychotic Agents

Identifiers

PMID25885367
PMCPMC4376086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.